Eli Lilly and Co banner

Eli Lilly and Co
XHAM:LLY

Watchlist Manager
Eli Lilly and Co Logo
Eli Lilly and Co
XHAM:LLY
Watchlist
Price: 895.9 EUR 0.38%
Market Cap: €857B

Profitability Summary

Eli Lilly and Co's profitability score is hidden . We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.

Sign Up to see
Profitability Score
Sign In
Sign Up

We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.

Sign Up to see
Profitability Score
Sign In
Sign Up

Margins

Earnings Waterfall
Eli Lilly and Co

Margins Comparison
Eli Lilly and Co Competitors

Country Company Market Cap Gross
Margin
Operating
Margin
Net
Margin
US
Eli Lilly and Co
NYSE:LLY
987B USD
Loading...
Loading...
Loading...
US
Johnson & Johnson
NYSE:JNJ
592.7B USD
Loading...
Loading...
Loading...
US
Abbvie Inc
NYSE:ABBV
403.4B USD
Loading...
Loading...
Loading...
CH
Roche Holding AG
SIX:ROG
295.7B CHF
Loading...
Loading...
Loading...
US
Merck & Co Inc
NYSE:MRK
309B USD
Loading...
Loading...
Loading...
US
Amgen Inc
NASDAQ:AMGN
205.6B USD
Loading...
Loading...
Loading...
US
Gilead Sciences Inc
NASDAQ:GILD
182.9B USD
Loading...
Loading...
Loading...
DK
Novo Nordisk A/S
CSE:NOVO B
1.1T DKK
Loading...
Loading...
Loading...
US
Pfizer Inc
NYSE:PFE
154.4B USD
Loading...
Loading...
Loading...
US
Bristol-Myers Squibb Co
NYSE:BMY
124.1B USD
Loading...
Loading...
Loading...
KR
Samsung Biologics Co Ltd
KRX:207940
136.7T KRW
Loading...
Loading...
Loading...

Return on Capital

Return on Capital Comparison
Eli Lilly and Co Competitors

Country Company Market Cap ROE ROA ROCE ROIC
US
Eli Lilly and Co
NYSE:LLY
987B USD
Loading...
Loading...
Loading...
Loading...
US
Johnson & Johnson
NYSE:JNJ
592.7B USD
Loading...
Loading...
Loading...
Loading...
US
Abbvie Inc
NYSE:ABBV
403.4B USD
Loading...
Loading...
Loading...
Loading...
CH
Roche Holding AG
SIX:ROG
295.7B CHF
Loading...
Loading...
Loading...
Loading...
US
Merck & Co Inc
NYSE:MRK
309B USD
Loading...
Loading...
Loading...
Loading...
US
Amgen Inc
NASDAQ:AMGN
205.6B USD
Loading...
Loading...
Loading...
Loading...
US
Gilead Sciences Inc
NASDAQ:GILD
182.9B USD
Loading...
Loading...
Loading...
Loading...
DK
Novo Nordisk A/S
CSE:NOVO B
1.1T DKK
Loading...
Loading...
Loading...
Loading...
US
Pfizer Inc
NYSE:PFE
154.4B USD
Loading...
Loading...
Loading...
Loading...
US
Bristol-Myers Squibb Co
NYSE:BMY
124.1B USD
Loading...
Loading...
Loading...
Loading...
KR
Samsung Biologics Co Ltd
KRX:207940
136.7T KRW
Loading...
Loading...
Loading...
Loading...

Free Cash Flow

Free Cash Flow Analysis
Eli Lilly and Co

Last Value
3-Years Average
FCF Margin
Conversion Rate
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett